Farther Finance Advisors’s aTyr Pharma ATYR Stock Holding History

Farther Finance Advisors’s Portfolio ATYR Stock Details ATYR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$222	Sell	372 -948	-72%	-$619	﹤0.01%	5702
2026 Q1	$1.12K	Sell	1,320 -905	-41%	-$764	﹤0.01%	5078
2025 Q4	$1.74K	Buy	2,225 +125	+6%	+$103	﹤0.01%	4743
2025 Q3	$1.51K	Sell	2,100 -17,823	-89%	-$80.8K	﹤0.01%	4237
2025 Q2	$101K	Sell	19,923 -4,500	-18%	-$17.7K	﹤0.01%	1760
2025 Q1	$70.3K	Hold	24,423	–	–	﹤0.01%	1705
2024 Q4	$88.4K	Sell	24,423 -9,000	-27%	-$27.3K	﹤0.01%	1359
2024 Q3	$58.8K	Buy	33,423 +3,000	+10%	+$5.46K	﹤0.01%	1564
2024 Q2	$47.5K	Buy	30,423 +100	+0.3%	+$174	﹤0.01%	1443
2024 Q1	$57.9K	Hold	30,323	–	–	﹤0.01%	1131
2023 Q4	$42.8K	Buy	+30,323	New	+$38.9K	﹤0.01%	1093

Other funds holding ATYR

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Farther Finance Advisors's ATYR Position: Q2 2026 in Review

Farther Finance Advisors reduced its aTyr Pharma (ATYR) stake by 72% in Q2 2026, selling an estimated $619 and leaving 372 shares worth $222. The position accounts for ﹤0.01% of the portfolio, ranked #5702.

Farther Finance Advisors first reported a position in ATYR in Q4 2023 and has held it in 11 quarters since. The position peaked at $101K in Q2 2025. 90 funds tracked by Wall St. Rank hold ATYR as of Q2 2026.

Farther Finance Advisors held 372 shares of aTyr Pharma worth $222 as of Q2 2026.
Farther Finance Advisors sold 948 aTyr Pharma shares in Q2 2026, an estimated $619.
aTyr Pharma made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5702 holding.
Farther Finance Advisors first reported a position in aTyr Pharma in Q4 2023 and has held it in 11 quarters since.
Farther Finance Advisors's aTyr Pharma position peaked at $101K in Q2 2025.
90 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.